Désolé, cet article est seulement disponible en anglais américain.
Cliquez pour voir la ligne de temps
Ligne de temps
Publications
Télécharger-
2019Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth, Nat. Immunol. 2019 Mar;20(3):257-264.
-
2018Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4, Clin. Exp. Immunol. 2018 Nov;194(2):166-179.
-
2017Measurement of Dipeptidylpeptidase Activity in vitro and in vivo., Bio Protoc 2017 Mar; 7(6): e2184.
-
2015RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells, Science. 2015 Sep 24. pii: aad0395. [Epub ahead of print].
-
2015Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy, Nat. Immunol. 2015 Aug;16(8):850-8.